Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

Brain Research

Volumn 841, Issue 1-2, 1999, Pages 160-169

  Tsukada, Hideo ^a   Nishiyama, Shingo ^a   Kakiuchi, Takeharu ^a   Ohba, Hiroyuki ^a   Sato, Kengo ^a   Harada, Norihiro ^a  

^a Central Research Laboratory   (Japan)

Author keywords

11C Raclopride; Dopamine; Dopamine D2 receptor; Microdialysis; Monkey brain; Positron emission tomography

Indexed keywords

BENZATROPINE; CARBON 11; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; KETANSERIN; METHAMPHETAMINE; RACLOPRIDE; SEROTONIN 2 ANTAGONIST; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DRUG BINDING; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MICRODIALYSIS; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; CARBON RADIOISOTOPES; CEREBELLUM; CONSCIOUSNESS; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; KINETICS; MACACA MULATTA; MALE; MICRODIALYSIS; PIPERAZINES; RACLOPRIDE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033546988     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01834-X     Document Type: Article

References (40)

1. Bacopoulos N.G., Redmond D.E., Roth R.H. Serotonin and dopamine metabolism in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine. J. Neurochem. 32:1979;1215-1218.
2. Baumann M.H., Char G.U., DeCosta B.R., Rice K.C., Rothman R.B. GBR12909 attenuate cocaine-induced activation of mesolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271:1994;1216-1222.
3. B.S. Bunney, G.K. Aghajanian, Dopaminergic influence in the basal ganglia: evidence for striatonigral feedback regulation, in: M. Yahr (Ed.), The Basal Ganglia, Raven Press, NY, 1976, pp. 249-267.
4. 11C ]raclopride binding with continuous infusion J. Cereb. Blood Flow Metab. 17:1997;437-447.
5. Dewey S.L., Brodie J.D., Fowler J.S., MacGregor R.R., Schlyer D.J., King P., Alexoff D., Volkow N.D., Shiue C.-Y., Wolf A.P., Bendriem B. Positron emission tomography (PET) studies of dopamine/cholinergic interactions in the baboon brain. Synapse. 6:1990;321-327.
6. 18F )-N-methylspiperidol binding in the baboon brain using positron emission tomography (PET) Synapse. 7:1991;324-427.
7. 11C -raclopride and positron emission tomography J. Neurosci. 12:1992;3773-3780.
8. 11C -raclopride is altered by drugs that modify synaptic dopamine levels Synapse. 13:1993;350-356.
9. Dewey S.L., Smith G.S., Logan J., Simkowitz P., Brodie J.D., Volkow N.D., Fowler J.S., Wolf A.P. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography (PET) in normal human subjects. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11816-11820.
10. Dewey S.L., Smith G.S., Logan J., Alexoff D., Ding Y.-S., King P., Pappas N., Brodie J.D., Ashby C.R. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15:1995;821-829.
11. Fink-Jensen A., Ingwersen S.H., Nielsen P.G., Hansen L., Nielsen E.B., Hansen A.J. Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine. Arch. Pharmacol. 350:1994;239-244.
12. French E. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol. Teratol. 16:1994;355-362.
13. Hattori T., Singh V.K., McGeer P.L., McGeer E.G. Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapse. Brain Res. 102:1976;164-173.
14. Huang S.H., Barrio J., Phelps M. Neuroreceptor assay with positron emission tomography; equilibrium versus dynamic approach. J. Cereb. Blood Flow Metab. 6:1986;515-521.
15. 2 receptor in nonhuman primates Synapse. 10:1992;177-184.
16. 3H ]raclopride in reserpine-treated mouse brain J. Neural Transm. 85:1991;1-10.
17. Kashihara K., Hamamura T., Okumura K., Otsuki S. Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528:1990;80-82.
18. 11C -raclopride against anesthetics in rhesus monkey brain J. Neural Transm. 100:1995;147-151.
19. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., Grasby P.M. Evidence for striatal dopamine release during a video game. Nature. 393:1998;266-268.
20. Koshikawa N., Tomiyama K., Omiya K., Kobayashi M. Ketamine anesthesia has no effect on striatal dopamine metabolism in rats. Brain Res. 444:1988;394-396.
21. Logan J., Dewey S.L., Wolf A.P., Fowler J., Brodie J.D., Angrist B., Volkow N.D., Gatley S.J. Effects of endogenous dopamine on measures of [F-18]NMSP binding in the basal ganglia: comparison of stimulations and experimental results from PET studies in baboons. Synapse. 9:1991;195-207.
22. Moghaddam B., Gruen R., Roth R., Bunney B., Adams R. Effects of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res. 518:1990;55-60.
23. Moghaddam B., Berridge C.W., Goldman-Rakic P.S., Bunney B.S., Roth R.H. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse. 13:1993;215-222.
24. 11C -methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey Brain Res. 663:1994;191-198.
25. Opacka-Juffry J., Ahier R.G., Cremer J.E. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anesthesia. Synapse. 7:1991;169-171.
26. 3H ]raclopride: implications for positron emission tomography of the human brain Synapse. 3:1989;96-97.
27. 11C -raclopride Soc. Neurosci. Abstr. 19:1993;128.
28. 11C -raclopride in normal human subjects Neuropsychopharmacology. 18:1997;18-25.
29. R. Snider, J.C. Lee, A Stereotactic Atlas of the Monkey Brain (Macaca mulatta), Chicago Univ. Press, Chicago, 1962.
30. Takechi H., Onoe H., Imamura K., Onoe K., Kakiuchi T., Nishiyama S., Yoshikawa E., Mori S., Kosugi T., Okada H., Tsukada H., Watanabe Y. Brain activation study by use of positron emission tomography in unanesthetized monkey. Neurosci. Lett. 182(1994):1994;279-282.
31. Tsukada H., Kakiuchi T., Ando I., Ouchi Y. Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a PET study in unanesthetized monkeys. J. Pharmacol. Exp. Ther. 281:1997;1408-1414.
32. Tsukada H., Kakiuchi T., Ando I., Shizuno H., Nakanishi S., Ouchi Y. Regulation of cerebral blood flow response to somatosensory stimulation through the cholinergic system: a PET study in unanesthetized monkey brain. Brain Res. 749:1997;10-17.
33. 2 receptors in the rat brain: an in vivo study using positron emission tomography. J. Neurosci. 16:1996;7670-7677.
34. 11C ]β-CFT in monkey brain under conscious and anesthesia conditions NeuroImage. 7:1998;A6.
35. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alteration performance in rats: modulation by dopamine. J. Neurosci. 16:1996;373-379.
36. Volkow N.D., Fowler J.S., Gatley S.J., Logan J., Wang G.J., Ding Y.S., Dewey S. PET evaluation of the dopamine system of the human brain. J. Nucl. Med. 37:1996;1242-1256.
37. Watanabe M., Okada H., Shimizu K., Omura T., Yoshikawa E., Kosugi T., Mori S., Yamashita T. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans. Nucl. Sci. 44:1997;1277-1282.
38. Weihmuller F.B., O'Dell S.J., Cole B.N., Marshall J.F. MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res. 549:1991;230-235.
39. Westerink B.H.C., Lejeune B., Korf H.M., Praag V. On the significance of regional metabolism in the rat brain for the classification of centrally acting drugs. Eur. J. Pharmacol. 42:1977;179-190.
40. 3H ]raclopride binding in the rat brain Synapse. 9:1991;188-194.